SCHEMBL30896396

SCHEMBL30896396

Cc1cc(-c2cc3c(cc2N)n(C)c(=O)n3C)ccn1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATAD2 Q6PL18 1/20 0.49
PDE3B Q13370 1/20 0.45
PDE3A Q14432 1/20 0.45
S100B P04271 1/20 0.42
CCNC P24863 2/20 0.40
CDK8 P49336 2/20 0.40
GRM2 Q14416 7/20 0.40
PIK3CB P42338 1/20 0.38
MAP4K4 O95819 2/20 0.37
CDC7 O00311 1/20 0.36
ROCK2 O75116 1/20 0.36
CDK2 P24941 1/20 0.36
GSK3B P49841 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
PDE10A Q9Y233 1/20 0.36
MTOR P42345 1/20 0.36
DYRK1A Q13627 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30896385 0.82 ATAD2 (0.54) ATAD2PDE3BPDE3AS100BPIK3CB
SCHEMBL30896317 0.79 MAPK14 (0.47) PDE3BPDE3AGRM2MAP4K4CDC7
SCHEMBL30896325 0.79 MAPT (0.44) PDE3BPDE3A
SCHEMBL30896404 0.78 KDM4E (0.44) CCNCCDK8PIK3CBMAP4K4PDE10A
SCHEMBL31613172 0.78 KDM4E (0.44) CCNCCDK8PIK3CBMAP4K4PDE10A
SCHEMBL30896383 0.76 ADORA2A (0.47) CCNCCDK8PIK3CBMAP4K4PDE10A
SCHEMBL30896357 0.75 CDC7 (0.41) CCNCCDK8GRM2PIK3CBMAP4K4
SCHEMBL31613173 0.75 CDC7 (0.41) CCNCCDK8GRM2PIK3CBMAP4K4
SCHEMBL30896384 0.71 MAPK1 (0.46)
SCHEMBL7086532 0.70 CCNC (0.43) CCNCCDK8PIK3CBMAP4K4CDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612128-A1 COMPOUNDS AND THEIR USE FOR TREATMENT OF HEMOGLOBINOPATHIES Bristol-Myers Squibb Company (US) 2025-09-10 EP disclosed
CN-120129677-A Compounds and their use for the treatment of heme lesions 百时美施贵宝公司 2025-06-10 CN disclosed
WO-2024097932-A1 COMPOUNDS AND THEIR USE FOR TREATMENT OF HEMOGLOBINOPATHIES BRISTOL-MYERS SQUIBB COMPANY (US) 2024-05-10 WO disclosed